A Study for Patients With Secondary Progressive Multiple Sclerosis
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MBP8298 is effective and safe in the
treatment secondary progressive multiple sclerosis.
Dirucotide is generic name for MBP8298.